2m 2m 2m 2m 2m 2m 2m
MAXCYTE (MXCT)
NASDAQ
$1.43-$0.04 (-2.72%)
Price as of Oct 22, 2026 7:30 PM EDT- $151.7MMarket Cap
- -10.91%1-Year Change
- Medical DevicesIndustry
MAXCYTE (MXCT)
$1.43-$0.04 (-2.72%)
MXCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.47 | ||
Change | +$0.04 (+2.80%) | ||
Open | $1.42 | ||
High | $1.53 | ||
Low | $1.41 | ||
Previous Close | $1.43 | ||
Volume | 1,423,125 | ||
30-Day Average Volume | 1,162,327 | ||
1-Week Change | 17.60% | ||
1-Month Change | 20.49% | ||
1-Year Change | -10.91% | ||
3-Year Change | -52.88% | ||
5-Year Change | -86.11% | ||
Fundamentals | |||
Shares Outstanding | 103.2M | ||
Total Assets | $184.7M | ||
Market Cap | $151.7M | ||
Enterprise Value | $136.7M | ||
Period: QTR TTM FY | |||
Revenue | $7.3M | ||
Net Income | -$8.9M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$8.9M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $111.4M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | 19 | ||
P/B | 1 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue